65,437 trials
Parkinson Disease
Primary: Percentage of Participants Who Experienced Adverse Events — 83.93; 83.93 percentage of participants
Depressive Disorder · Cancer
Primary: Number of Participants Diagnosed With Any of the Cancers Under Investigation Who Were Regularly Exposed to the Indicated Antidepressant — 853; 4561; 1963; 2570…
Asthma
Primary: Mean Percent Change of Forced Expiratory Volume in One Second (FEV1) From Baseline to Week 12. — -1.09; -0.02 Percent Change of FEV1 — p=0.4982
Atrial Fibrillation · Stroke
Primary: Yearly Event Rate for Composite Endpoint of Stroke/SEE — 1.54; 1.11; 1.71 yearly event rate (percentage) — p=<.0001
Tetanus · Acellular Pertussis · Diphtheria
Primary: Number of Subjects With Booster Responses to Diphteria and Tetanus — 209; 207; 208; 203 Participants
Corneal Infiltrates
Primary: Cumulative Incidence of Corneal Inflammatory Events — 26.7 annual incidence per 100 subjects
HIV Infections · Tuberculosis
Primary: Number of Participants With Microbiologically Confirmed Tuberculosis Infection — 20 participants
Asthma · Airway Inflammation
Primary: Mean Percent Change From Baseline to Day 14 in Exhaled Nitric Oxide (eNO) Parts Per Billion (Ppb) — -35.3; -45.4; -61.4; -51.3 percentage of eNO — p=<0.001
Rheumatoid Arthritis
Primary: Percent of Patients Who Achieved a EULAR (The European League Against Rheumatism) Response at Week 10 — 49.7 Percentage
Vulvodynia
Primary: Mean Marinoff Dyspareunia Scale Score (MDSS) at End of Treatment (12 Weeks) — 1.8; 1.8; 1.7 scores on a scale
Pelvic Pain
Primary: Pain Score — 7.1; 6.4; 6.9 Units on a scale
Breast Cancer
Primary: Time to Progression (TTP) — 10.8; 10.2 months
Puberty, Precocious
Primary: Percentage of Participants With Suppression of Peak Stimulated Luteinizing Hormone (<4 mIU/mL) From Month 2 Through Month 6 — 76.2; 80.7; 90.5; 100 Percentage of…
Contact Lens Solutions
Primary: Antimicrobial Efficacy — 114; 219; 0; 3 Eyes
Hypertension
Primary: Change in Mean Sitting Diastolic Blood Pressure (msDBP) From Baseline to End of Study (Week 8) — -9.7; -7.1 mmHg